These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12809455)

  • 1. A physiologic approach to diagnosis of the Cushing syndrome.
    Raff H; Findling JW
    Ann Intern Med; 2003 Jun; 138(12):980-91. PubMed ID: 12809455
    [No Abstract]   [Full Text] [Related]  

  • 2. Disorders of the hypothalamic-pituitary-adrenal axis.
    Wand GS; Ney RL
    Clin Endocrinol Metab; 1985 Feb; 14(1):33-53. PubMed ID: 2990779
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypothalamo-pituitary-adrenal cortex system and the glucocorticoid kinetics in Cushing's syndrome treated with chlodithane and large doses of reserpine].
    Slavnov VN; Luchitskiĭ EV; Komissarenko IV; Markov VV; Cheban AK
    Ter Arkh; 1980; 52(7):124-8. PubMed ID: 6105729
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cushing's syndrome; optimalization of the diagnosis].
    de Herder WW; van der Lely AJ; de Jong FH; Lamberts SW
    Ned Tijdschr Geneeskd; 1996 Jul; 140(28):1449-54. PubMed ID: 8766769
    [No Abstract]   [Full Text] [Related]  

  • 5. [Corticotropin releasing factor (CRF)-stimulating test in patients with disorders of the hypothalamo-pituitary-adrenal axis].
    Hashimoto K; Murakami K; Hattore T; Ota Z
    Nihon Naika Gakkai Zasshi; 1984 Sep; 73(9):1317-24. PubMed ID: 6097622
    [No Abstract]   [Full Text] [Related]  

  • 6. Cushing's Syndrome in a 6-month-old Boy: A Rare Side-effect due to Inadequate use of Topical Corticosteroids.
    Ciccone S; Marini R; Bizzarri C; El Hachem M; Cappa M
    Acta Derm Venereol; 2016 Jan; 96(1):138-9. PubMed ID: 26038976
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical significance of the diagnostic use and assay of corticotropin-releasing hormone in the physiopathologic state of the hypothalamo-pituitary-adrenal axis].
    Nishikawa T; Yoshida A; Mikami K; Tamura Y; Yoshida S
    Nihon Rinsho; 1990 Feb; 48 Suppl():182-4. PubMed ID: 2162415
    [No Abstract]   [Full Text] [Related]  

  • 8. Human studies on hypothalamo-pituitary-adrenal (HPA) axis.
    Liyanarachchi K; Ross R; Debono M
    Best Pract Res Clin Endocrinol Metab; 2017 Oct; 31(5):459-473. PubMed ID: 29223281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New targets for the clinical assessment of salivan cortisol secretion.
    Rosmond R; Björntorp P
    J Endocrinol Invest; 2001 Sep; 24(8):639-41. PubMed ID: 11686548
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypercortisolemia and depression.
    Gillespie CF; Nemeroff CB
    Psychosom Med; 2005; 67 Suppl 1():S26-8. PubMed ID: 15953796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnosis and differential diagnosis of endogenous Cushing's syndrome.
    Makras P; Toloumis G; Papadogias D; Kaltsas GA; Besser M
    Hormones (Athens); 2006; 5(4):231-50. PubMed ID: 17178699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are we in danger from an epidemic of Cushing's syndrome? Nature knows its course.
    Weaver JU
    Clin Endocrinol (Oxf); 2001 Dec; 55(6):719-21. PubMed ID: 11895210
    [No Abstract]   [Full Text] [Related]  

  • 13. Serotonin, Cushing's disease, and depression.
    Sonino N; Fava GA
    Psychother Psychosom; 1996; 65(2):63-5. PubMed ID: 8711083
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathophysiological interpretation of the Cushing's syndrome as the clinical picture of pathological hyperfunction of the neuroglandular circuit: hypothalamus-adenohypophysis-suprarenal gland cortex.
    Hrbek V
    Acta Univ Palacki Olomuc Fac Med; 1976; 80():147-55. PubMed ID: 1053392
    [No Abstract]   [Full Text] [Related]  

  • 15. [The function of the hypothalamo-hypophyseal-adrenal system in Itsenko-Cushing syndrome].
    Luchitskiĭ EV; Valueva GV; Markov VV; Slavnov VN; Rybakov SI
    Probl Endokrinol (Mosk); 1989; 35(6):38-42. PubMed ID: 2560186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Work-related stress and the hypothalamic-pituitary-adrenal axis].
    Rotvig DH; Bauer JØ; Eller NH; Jørgensen MB
    Ugeskr Laeger; 2019 Feb; 181(7):. PubMed ID: 30777591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing the development of glucose intolerance in Cushing syndrome.
    Kreze A; Mikulecky M; Moravcik M
    Acta Med Austriaca; 1995; 22(5):110-2. PubMed ID: 8651039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interrelation of disorders in gonadotropin and prolactin secretion and the activity of the hypothalamo-hypophyseal-adrenal system in Itsenko-Cushing disease].
    Manusharova RA; Cheban AK; Komissarenko IV; Slavnov VN; Veĭnberg EG
    Probl Endokrinol (Mosk); 1984; 30(4):31-5. PubMed ID: 6089167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The hypothalamo-hypophyseal-adrenal gland system and steroid glaucoma].
    Schwartz B
    Klin Monbl Augenheilkd; 1972 Sep; 161(3):280-7. PubMed ID: 4567239
    [No Abstract]   [Full Text] [Related]  

  • 20. Harmful effects of functional hypercortisolism: a working hypothesis.
    Tirabassi G; Boscaro M; Arnaldi G
    Endocrine; 2014 Aug; 46(3):370-86. PubMed ID: 24282037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.